These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17434154)

  • 1. A systematic bioinformatics approach for selection of epitope-based vaccine targets.
    Khan AM; Miotto O; Heiny AT; Salmon J; Srinivasan KN; Nascimento EJ; Marques ET; Brusic V; Tan TW; August JT
    Cell Immunol; 2006 Dec; 244(2):141-7. PubMed ID: 17434154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection.
    Weiskopf D; Angelo MA; Sidney J; Peters B; Shresta S; Sette A
    J Virol; 2014 Oct; 88(19):11383-94. PubMed ID: 25056881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inferring Protective CD8+ T-Cell Epitopes for NS5 Protein of Four Serotypes of Dengue Virus Chinese Isolates Based on HLA-A, -B and -C Allelic Distribution: Implications for Epitope-Based Universal Vaccine Design.
    Shi J; Sun J; Wu M; Hu N; Li J; Li Y; Wang H; Hu Y
    PLoS One; 2015; 10(9):e0138729. PubMed ID: 26381649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-based vaccines generate cytotoxic T lymphocytes to epitopes of NS1 from dengue virus that are present in all major serotypes.
    Gao G; Wang Q; Dai Z; Calcedo R; Sun X; Li G; Wilson JM
    Hum Gene Ther; 2008 Sep; 19(9):927-36. PubMed ID: 18788905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring dengue genome to construct a multi-epitope based subunit vaccine by utilizing immunoinformatics approach to battle against dengue infection.
    Ali M; Pandey RK; Khatoon N; Narula A; Mishra A; Prajapati VK
    Sci Rep; 2017 Aug; 7(1):9232. PubMed ID: 28835708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational approach for identification of epitopes in dengue virus envelope protein: a step towards designing a universal dengue vaccine targeting endemic regions.
    Chakraborty S; Chakravorty R; Ahmed M; Rahman A; Waise TM; Hassan F; Rahman M; Shamsuzzaman S
    In Silico Biol; 2010; 10(5-6):235-46. PubMed ID: 22430357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of amino acids involved in recognition by dengue virus NS3-specific, HLA-DR15-restricted cytotoxic CD4+ T-cell clones.
    Zeng L; Kurane I; Okamoto Y; Ennis FA; Brinton MA
    J Virol; 1996 May; 70(5):3108-17. PubMed ID: 8627790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of novel Dengue virus epitopes identified by bioinformatic analysis.
    Sánchez-Burgos G; Ramos-Castañeda J; Cedillo-Rivera R; Dumonteil E
    Virus Res; 2010 Oct; 153(1):113-20. PubMed ID: 20638434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T Cell Responses Induced by DNA Vaccines Based on the DENV2 E and NS1 Proteins in Mice: Importance in Protection and Immunodominant Epitope Identification.
    Pinto PBA; Assis ML; Vallochi AL; Pacheco AR; Lima LM; Quaresma KRL; Pereira BAS; Costa SM; Alves AMB
    Front Immunol; 2019; 10():1522. PubMed ID: 31333657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-serotypically conserved epitope recommendations for a universal T cell-based dengue vaccine.
    Ahmed SF; Quadeer AA; Barton JP; McKay MR
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008676. PubMed ID: 32956362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sculpting the immunological response to dengue fever by polytopic vaccination.
    Zhou H; Deem MW
    Vaccine; 2006 Mar; 24(14):2451-9. PubMed ID: 16417956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus.
    Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M
    Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of cytotoxic T lymphocyte epitopes in dengue virus serotype 1.
    Duan Z; Guo J; Huang X; Liu H; Chen X; Jiang M; Wen J
    J Med Virol; 2015 Jul; 87(7):1077-89. PubMed ID: 25777343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and immunogenicity of two new HLA-A*0201-restricted CD8+ T-cell epitopes on dengue NS1 protein.
    Tian J; Zeng G; Pang X; Liang M; Zhou J; Fang D; Liu Y; Li D; Jiang L
    Int Immunol; 2012 Apr; 24(4):207-18. PubMed ID: 22298881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An immunoinformatics-derived DNA vaccine encoding human class II T cell epitopes of Ebola virus, Sudan virus, and Venezuelan equine encephalitis virus is immunogenic in HLA transgenic mice.
    Bounds CE; Terry FE; Moise L; Hannaman D; Martin WD; De Groot AS; Suschak JJ; Dupuy LC; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):2824-2836. PubMed ID: 28575582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic Mice.
    Roth C; Cantaert T; Colas C; Prot M; Casadémont I; Levillayer L; Thalmensi J; Langlade-Demoyen P; Gerke C; Bahl K; Ciaramella G; Simon-Loriere E; Sakuntabhai A
    Front Immunol; 2019; 10():1424. PubMed ID: 31293584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
    McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
    Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.
    de Alwis R; Bangs DJ; Angelo MA; Cerpas C; Fernando A; Sidney J; Peters B; Gresh L; Balmaseda A; de Silva AD; Harris E; Sette A; Weiskopf D
    J Virol; 2016 May; 90(9):4771-4779. PubMed ID: 26912627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservation and variability of dengue virus proteins: implications for vaccine design.
    Khan AM; Miotto O; Nascimento EJ; Srinivasan KN; Heiny AT; Zhang GL; Marques ET; Tan TW; Brusic V; Salmon J; August JT
    PLoS Negl Trop Dis; 2008 Aug; 2(8):e272. PubMed ID: 18698358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct activation phenotype of a highly conserved novel HLA-B57-restricted epitope during dengue virus infection.
    Townsley E; Woda M; Thomas SJ; Kalayanarooj S; Gibbons RV; Nisalak A; Srikiatkhachorn A; Green S; Stephens HA; Rothman AL; Mathew A
    Immunology; 2014 Jan; 141(1):27-38. PubMed ID: 23941420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.